Tamara van Donge

Efficacy and safety of amoxicillin in neonates 73 4 17. Muller-Pebody B, Johnson A, Heath P, et al. Empirical treatment of neonatal sepsis: are the current guidelines adequate? Archives of Disease in Childhood-Fetal and Neonatal Edition. 2011;96(1):F4- F8. 18. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical infectious diseases. 1998;26(1):1-10. 19. Lodise TP, Lomaestro BM, Drusano GL. Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on β‐lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2006;26(9):1320-1332. 20. Wong G, Sime FB, Lipman J, Roberts JA. How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients? BMC infectious diseases. 2014;14(1):288. 21. Mouton JW, Brown D, Apfalter P, et al. The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clinical Microbiology and Infection. 2012;18(3):E37-E45. 22. Shaffer CL, Davey AM, Ransom JL, Brown YL, Gal P. Ampicillin-induced neurotoxicity in very-low- birth-weight neonates. Annals of Pharmacotherapy. 1998;32(4):482-484. 23. Strunk T, Richmond P, Simmer K, Currie A, Levy O, Burgner D. Neonatal immune responses to coagulase-negative staphylococci. Current opinion in infectious diseases. 2007;20(4):370-375. 24. Abdul-Aziz MH, Dulhunty JM, Bellomo R, Lipman J, Roberts JA. Continuous beta-lactam infusion in critically ill patients: the clinical evidence. Annals of Intensive Care. 2012;2(1):37. 25. Payne LE, Gagnon DJ, Riker RR, et al. Cefepime-induced neurotoxicity: a systematic review. Critical Care. 2017;21(1):276. 26. Mattappalil A, Mergenhagen KA. Neurotoxicity with antimicrobials in the elderly: a review. Clinical therapeutics. 2014;36(11):1489-1511. e1484. 27. Quinton M-C, Bodeau S, Kontar L, et al. Neurotoxic concentration of piperacillin during continuous infusion in critically ill patients. Antimicrobial agents and chemotherapy. 2017;61(9):e00654-00617. 28. Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. British journal of clinical pharmacology. 2011;72(3):381-393. 29. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. Jama. 2004;292(19):2357-2365. 30. Savioli K, Rouse C, Susi A, Gorman G, Hisle-Gorman E. Suspected or known neonatal sepsis and neurodevelopmental delay by 5 years. Journal of Perinatology. 2018:1.